294 related articles for article (PubMed ID: 25240098)
41. Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus.
da Rosa R; Zimmermann LA; de Moraes MH; Schneider NFZ; Schappo AD; Simões CMO; Steindel M; Schenkel EP; Bernardes LSC
Bioorg Med Chem Lett; 2018 Nov; 28(20):3381-3384. PubMed ID: 30194008
[TBL] [Abstract][Full Text] [Related]
42. Screening of agelasine D and analogs for inhibitory activity against pathogenic protozoa; identification of hits for visceral leishmaniasis and Chagas disease.
Vik A; Proszenyák A; Vermeersch M; Cos P; Maes L; Gundersen LL
Molecules; 2009 Jan; 14(1):279-88. PubMed ID: 19136916
[TBL] [Abstract][Full Text] [Related]
43. Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
Ramírez-Macías I; Marín C; Es-Samti H; Fernández A; Guardia JJ; Zentar H; Agil A; Chahboun R; Alvarez-Manzaneda E; Sánchez-Moreno M
Parasitol Int; 2012 Sep; 61(3):405-13. PubMed ID: 22366342
[TBL] [Abstract][Full Text] [Related]
44. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
[TBL] [Abstract][Full Text] [Related]
45. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
[TBL] [Abstract][Full Text] [Related]
46. Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.
Moraes CB; Giardini MA; Kim H; Franco CH; Araujo-Junior AM; Schenkman S; Chatelain E; Freitas-Junior LH
Sci Rep; 2014 Apr; 4():4703. PubMed ID: 24736467
[TBL] [Abstract][Full Text] [Related]
47. In vitro investigation of the efficacy of novel diamidines against Trypanosoma cruzi.
Timm BL; Da Silva PB; Batista MM; Farahat AA; Kumar A; Boykin DW; Soeiro MN
Parasitology; 2014 Sep; 141(10):1272-6. PubMed ID: 24735493
[TBL] [Abstract][Full Text] [Related]
48. Manadoperoxides, a new class of potent antitrypanosomal agents of marine origin.
Chianese G; Fattorusso E; Scala F; Teta R; Calcinai B; Bavestrello G; Dien HA; Kaiser M; Tasdemir D; Taglialatela-Scafati O
Org Biomol Chem; 2012 Sep; 10(35):7197-207. PubMed ID: 22859016
[TBL] [Abstract][Full Text] [Related]
49. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds.
Cerecetto H; González M
Mini Rev Med Chem; 2008 Nov; 8(13):1355-83. PubMed ID: 18991753
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of NAD+-dependent histone deacetylases (sirtuins) causes growth arrest and activates both apoptosis and autophagy in the pathogenic protozoan Trypanosoma cruzi.
Veiga-Santos P; Reignault LC; Huber K; Bracher F; De Souza W; De Carvalho TM
Parasitology; 2014 May; 141(6):814-25. PubMed ID: 24670415
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents.
Silva TB; Ji KNK; Petzold Pauli F; Galvão RMS; Faria AFM; Bello ML; Resende JALC; Campos VR; Forezi LDSM; da Silva FC; Faria RX; Ferreira VF
Bioorg Chem; 2021 Nov; 116():105250. PubMed ID: 34469833
[TBL] [Abstract][Full Text] [Related]
52. Discovery of Strong 3-Nitro-2-Phenyl-
Carey SM; O'Neill DM; Conner GB; Sherman J; Rodriguez A; D'Antonio EL
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673904
[TBL] [Abstract][Full Text] [Related]
53. In vivo trypanosomicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against acute and chronic phases of Chagas disease.
Sánchez-Moreno M; Sanz AM; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macias I; Rosales MJ; Olmo F; Garcia-Aranda I; Campayo L; Cano C; Arrebola F; Yunta MJ
J Med Chem; 2011 Feb; 54(4):970-9. PubMed ID: 21229977
[TBL] [Abstract][Full Text] [Related]
54. Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruzi activity in immunodeficient-mouse mode of infection.
Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Olmo F; Yunta MJ; Sanz AM; Rosales MJ; Cano C; Campayo L
J Med Chem; 2012 Nov; 55(22):9900-13. PubMed ID: 23043291
[TBL] [Abstract][Full Text] [Related]
55. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.
Honorato SB; Mendonça JS; Boechat N; Oliveira AC; Mendes Filho J; Ellena J; Ayala AP
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():389-94. PubMed ID: 24076454
[TBL] [Abstract][Full Text] [Related]
56. Identification of Novel Functionalized Carbohydrazonamides Designed as Chagas Disease Drug Candidates.
do Nascimento MSS; Câmara VRF; da Costa JS; Barbosa JMC; Lins ASM; Salomão K; de Castro SL; Carvalho SA; da Silva EF; Fraga CAM
Med Chem; 2020; 16(6):774-783. PubMed ID: 31244442
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo activity of the chloroaryl-substituted imidazole viniconazole against Trypanosoma cruzi.
Silva CF; Batista Dda G; Batista MM; Lionel J; Hammer ER; Brun R; Soeiro Mde N
Parasitology; 2014 Mar; 141(3):367-73. PubMed ID: 24553079
[TBL] [Abstract][Full Text] [Related]
58. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi.
Molina J; Brener Z; Romanha AJ; Urbina JA
J Antimicrob Chemother; 2000 Jul; 46(1):137-40. PubMed ID: 10882704
[TBL] [Abstract][Full Text] [Related]
59. Selective activity of 2,4-diaryl-1,2,3,4-tetrahydroquinolines on Trypanosoma cruzi epimastigotes and amastigotes expressing β-galactosidase.
Fonseca-Berzal C; Merchán Arenas DR; Romero Bohórquez AR; Escario JA; Kouznetsov VV; Gómez-Barrio A
Bioorg Med Chem Lett; 2013 Sep; 23(17):4851-6. PubMed ID: 23899616
[TBL] [Abstract][Full Text] [Related]
60. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
Villarreal D; Barnabé C; Sereno D; Tibayrenc M
Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]